Shaik Syed Ali P, Ahmad M, Parveen K
Mol Biol Rep. 2025; 52(1):311.
PMID: 40085362
DOI: 10.1007/s11033-025-10413-6.
Lambrechts Y, Hatse S, Richard F, Boeckx B, Floris G, Desmedt C
Cancers (Basel). 2023; 15(17).
PMID: 37686617
PMC: 10486668.
DOI: 10.3390/cancers15174341.
Mishra A, Banday S, Bharadwaj R, Ali A, Rashid R, Kulshreshtha A
Vaccines (Basel). 2023; 11(1).
PMID: 36679900
PMC: 9863216.
DOI: 10.3390/vaccines11010055.
Tran F, Lee E, Cuddapah S, Choi B, Dai W
Cancers (Basel). 2022; 14(23).
PMID: 36497298
PMC: 9741118.
DOI: 10.3390/cancers14235818.
Qin R, Ren W, Ya G, Wang B, He J, Ren S
Clin Exp Med. 2022; 23(5):1359-1373.
PMID: 36173487
PMC: 10460746.
DOI: 10.1007/s10238-022-00888-z.
CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway.
Huang X, Lai S, Qu F, Li Z, Fu X, Li Q
Mol Ther Oncolytics. 2022; 25:1-15.
PMID: 35399607
PMC: 8971730.
DOI: 10.1016/j.omto.2022.03.004.
Non-Coding RNAs in the Crosstalk between Breast Cancer Cells and Tumor-Associated Macrophages.
Benedetti A, Turco C, Fontemaggi G, Fazi F
Noncoding RNA. 2022; 8(1).
PMID: 35202089
PMC: 8874851.
DOI: 10.3390/ncrna8010016.
Tumor-associated macrophages in osteosarcoma.
Zhao Y, Zhang B, Zhang Q, Ma X, Feng H
J Zhejiang Univ Sci B. 2021; 22(11):885-892.
PMID: 34783219
PMC: 8593527.
DOI: 10.1631/jzus.B2100029.
A multi-cellular molecular signaling and functional network map of C-C motif chemokine ligand 18 (CCL18): a chemokine with immunosuppressive and pro-tumor functions.
Aravind A, Palollathil A, Rex D, Kumar K, Vijayakumar M, Shetty R
J Cell Commun Signal. 2021; 16(2):293-300.
PMID: 34196939
PMC: 8891403.
DOI: 10.1007/s12079-021-00633-3.
Research trends in pharmacological modulation of tumor-associated macrophages.
Wang N, Wang S, Wang X, Zheng Y, Yang B, Zhang J
Clin Transl Med. 2021; 11(1):e288.
PMID: 33463063
PMC: 7805405.
DOI: 10.1002/ctm2.288.
CCL18 in the Progression of Cancer.
Korbecki J, Olbromski M, Dziegiel P
Int J Mol Sci. 2020; 21(21).
PMID: 33114763
PMC: 7663205.
DOI: 10.3390/ijms21217955.
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y
Theranostics. 2020; 10(25):11535-11548.
PMID: 33052231
PMC: 7546008.
DOI: 10.7150/thno.45261.
miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
Hannafon B, Cai A, Calloway C, Xu Y, Zhang R, Fung K
BMC Cancer. 2019; 19(1):642.
PMID: 31253120
PMC: 6599331.
DOI: 10.1186/s12885-019-5839-2.
microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2.
Wang M, Zhang H, Li J, Zhao H
Biosci Rep. 2018; 38(5).
PMID: 30049846
PMC: 6146293.
DOI: 10.1042/BSR20180571.
MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma.
Li L, Sun P, Zhang C, Li Z, Cui K, Zhou W
Cancer Cell Int. 2018; 18:95.
PMID: 29989015
PMC: 6035433.
DOI: 10.1186/s12935-018-0590-3.
Breast cancer lung metastasis: Molecular biology and therapeutic implications.
Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X
Cancer Biol Ther. 2018; 19(10):858-868.
PMID: 29580128
PMC: 6300341.
DOI: 10.1080/15384047.2018.1456599.
The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway.
Li T, Sun X, Xu K
Cell Biosci. 2018; 8:17.
PMID: 29507713
PMC: 5833031.
DOI: 10.1186/s13578-018-0212-8.
Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.
Tripathi K, Garg M
J Cell Commun Signal. 2018; 12(3):513-527.
PMID: 29330773
PMC: 6039341.
DOI: 10.1007/s12079-017-0441-3.
Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species.
Davis L, Jeng S, Svalina M, Huang E, Pittsenbarger J, Cantor E
Oncotarget. 2017; 8(44):76241-76256.
PMID: 29100308
PMC: 5652702.
DOI: 10.18632/oncotarget.19532.
Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.
Wang H, Liang X, Li M, Tao X, Tai S, Fan Z
Cancer Sci. 2017; 108(8):1584-1593.
PMID: 28574664
PMC: 5543498.
DOI: 10.1111/cas.13289.